Sort
51,593 grants matching “hepatitis”
Impact of HIV on Hepatitis C Infection in Hemophilia
$515,165University Of Pittsburgh At Pittsburgh · R01 · FY2002 · HL
Geranylgeranyl diphosphate synthase inhibitor therapy for multiple myeloma
$515,150Sarah A Holstein · University Of Nebraska Medical Center · R01 · FY2021 · CA
Tumor-promoting and tumor-suppressive roles of Hepatic Stellate Cell Subpopulations in NASH-HCC
$515,123Robert F. Schwabe · Columbia University Health Sciences · R01 · FY2022 · CA
Effects of mu-opiate receptor engagement on microbial translocation and residual immune activation in HIV-infected, ART suppressed opioid use disorder patents initiating medication-assisted treatment
$515,107Luis J. Montaner · Wistar Institute · R01 · FY2019 · DA
Project 2: The Impact of Immunotherapy on Human Vaccination
$515,006E. John Wherry · Massachusetts General Hospital · U19 · FY2020 · AI
Host Genetic Contribution to HCV Outcomes
$514,999Ronald E. Blanton · Case Western Reserve University · R01 · FY2009 · AI
Accurate Measurement of Renal Function in Cirrhosis
$514,948Vivian S Lee · University Of Utah · R01 · FY2012 · DK
Delineating the molecular mechanisms of hepatocyte-to-cholangiocyte reprogramming
$514,858Donghun Shin · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · DK
PREVENTION OF HIV AMONG NEW IDUS AND NON-IDUS IN HARLEM
$514,837New York Academy Of Medicine · R01 · FY2003 · DA
Noninvasive Portal Pressure Measurements in Children
$514,832Flemming Forsberg · Thomas Jefferson University · R01 · FY2020 · DK
Lipid-Responsive E3 ubiquitin ligases in cholesterol metabolism and atheroscierosis
$514,800Peter J Tontonoz · University Of California Los Angeles · R01 · FY2020 · HL
Lipid-Responsive E3 ubiquitin ligases in cholesterol metabolism and atheroscierosis
$514,800Peter J Tontonoz · University Of California Los Angeles · R01 · FY2019 · HL
Lipid-Responsive E3 ubiquitin ligases in cholesterol metabolism and atheroscierosis
$514,800Peter J Tontonoz · University Of California Los Angeles · R01 · FY2021 · HL
Mechanisms of T Cell Memory Quiescence
$514,790Surojit Sarkar · Seattle Children'S Hospital · R01 · FY2022 · AI
Mechanisms of T Cell Memory Quiescence
$514,790Surojit Sarkar · Seattle Children'S Hospital · R01 · FY2021 · AI
Regulation of Net Hepatic Glucose Uptake in Vivo
$514,781Vanderbilt University · R01 · FY2005 · DK
Novel regulatory mechanisms control IFNL3 expression during HCV infection
$514,747Ram Savan · University Of Washington · R01 · FY2017 · AI
Integration of Feeding Time and Glucose Metabolism by the Circadian Gene Network
$514,737Joseph T Bass · Northwestern University At Chicago · R01 · FY2016 · DK
Increasing Uptake of Evidence Based Screening Services though a CHW-led multi-modality program: The South Florida Center for Reducing Health Disparities
$514,693Olveen Carrasquillo · University Of Miami School Of Medicine · U01 · FY2016 · MD
Genetic Determinants of Weight Loss and Resolution of Co-Morbidities
$514,689Glenn S Gerhard · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2014 · DK
HIV-Infected IDU Living with HCV Coinfection
$514,650Columbia University Health Sciences · R01 · FY2005 · DA
Type I Interferon-Regulated T Helper Development
$514,631John David Farrar · Ut Southwestern Medical Center · R01 · FY2010 · AI
Environmental Factors in HIV Transmission among Suburban IDUs
$514,477Robert Heimer · Yale University · R01 · FY2007 · DA
NATURAL HISTORY OF HEPATITIS C INFECTION IN HIV DISEASE
$514,420Boston Medical Center · R01 · FY2000 · DK
Critical Lipid Species in the Hepatovirus Lifecycle
$514,390Stanley M Lemon · Univ Of North Carolina Chapel Hill · R01 · FY2021 · AI